Chinese Omicron-specific mRNA Covid vaccine to be trialled in UAE
China's Suzhou Abogen Biosciences Co said its Covid-19 vaccine candidate using the messenger RNA (mRNA) technology and targeting the Omicron variant has obtained clinical trial approval in the United Arab Emirates (UAE).
With Friday's announcement, Abogen joins Pfizer/BioNTech and Moderna in trialing candidates modified specifically against Omicron, a highly transmissible variant.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.